Drugs.com

MAY 20, 2024

MONDAY, May 20, 2024 -- Women treated for infertility were twice as likely as those who conceived naturally to be hospitalized with heart disease within a year of delivery, recent research shows.They are particularly likely to land in the hospital.

Treatment 173

Treatment Hospitals Disease Research 173

Drugs.com

OCTOBER 8, 2024

8, 2024 -- AI isn’t ready to run a hospital’s emergency room just yet, a new study concludes.ChatGPT likely would ask for unnecessary x-rays and antibiotics for some patients, and admit others who don’t really need hospital treatment. TUESDAY, Oct.

Hospitals 246

Hospitals Treatment 246

Drugs.com

OCTOBER 31, 2023

31, 2023 -- In some big cities, mobile stroke units can deliver a powerful clot-busting drug to patients as these specialized ambulances speed to the hospital. Now, a new study shows these units deliver anti-clotting treatment a. TUESDAY, Oct.

Hospitals 246

Hospitals Treatment Drugs 246

SCIENMAG: Medicine & Health

FEBRUARY 9, 2024

CLEVELAND—University Hospitals (UH) Brain Health & Memory Center is now treating patients with LEQEMBI® (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease.

Hospitals 79

Hospitals FDA Approval Treatment Disease 79

Science Daily: Pharmacology News

DECEMBER 1, 2023

Researchers give medieval Cambridge residents the 'Richard III treatment' to reveal hard-knock lives of those in the city during its famous university's early years. Study of over 400 remains from a hospital cemetery shows spectrum of medieval poverty, and suggests that some of Cambridge University's earliest scholars ended up in penury.

Hospitals 239

Hospitals Treatment Research 239

Drugs.com

MARCH 25, 2024

MONDAY, March 25, 2024 — Men with prostate cancer treated at hospitals participating in a special drug-pricing program were more likely to stick to their therapy than patients elsewhere, new research reveals.The federal 340B Drug Program requires.

Treatment 147

Treatment Hospitals Therapies Research 147

Drug Target Review

JUNE 5, 2025

Dr Aaron Haubner, Senior Manager of North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies , reveals that while promising new treatments emerge, urgent partnerships are needed to ensure this essential blood therapy reaches the patients who need it most.

Disease 52

Disease Treatment Therapies Nurses 52

Broad Institute

MAY 19, 2025

The findings could shed light on the biological basis of these conditions and help scientists develop better diagnostics and treatments. Eating disorders are estimated to affect nearly 30 million Americans, although most arent receiving treatment. The team has already recruited almost 3,000 participants from all 50 states.

DNA 88

DNA Medical Schools Treatment Hospitals 88

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

Kendal Chidwick NDARC’s Kendal Chidwick discusses the findings from a recently published study that examined how patterns of opioid agonist treatment medicines have changed over the past decade. Other changes around this time aimed at improving treatment accessibility included increased use of take-home doses and telehealth appointments.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Broad Institute

NOVEMBER 7, 2023

While RA therapies targeted to specific inflammatory pathways have emerged, only some patients’ symptoms improve with treatment, emphasizing the need for multiple treatment approaches tailored to different disease subtypes. They also found that patients’ CTAPs were dynamic and could change over time in response to treatment.

Treatment 96

Treatment RNA Hospitals Disease 96

Drug Target Review

MAY 21, 2025

At the forefront of this mission is Senior Vice President of Vitalant, Becky Butler Cap, whose career has been long defined by a passion for building new services and treatment options in emerging markets. Building new services and treatment options for patients are a passion for me.

Therapies 52

Therapies Hospitals Production Treatment 52

Drug Discovery Today

MAY 1, 2020

Oxford BioDynamics’ EpiSwitch technology has been chosen as the biomarker platform for prognostic and predictive profiling of COVID-19 patients in the GETAFIX clinical study.Institute of Infection, Immunity and Inflammation, University of Glasgow, and NHS Scotland are leading the effort to identify patients at risk of severe immune complications and (..)

Treatment 100

Treatment Hospitals Disease 100

Common Sense for Drug Policy Blog

OCTOBER 7, 2023

Changes in the risk of hospital admissions with injecting-related infections in and out of prison and OAT may also reflect changes in the ability to access primary and secondary health services. 2012 ; Joudrey et al., 2019 ; Treloar et al., 2014 ; Joudrey et al., 2019 ), which likely increases overdose risk more so than infection risk.

Hospitals 52

Hospitals Treatment International Drugs 52

Broad Institute

OCTOBER 21, 2024

By Leah Eisenstadt October 21, 2024 Credit: Kevin Middleton, Broad Communications In the Bhattacharyya lab, researchers develop methods to quickly identify the most appropriate treatments for bacterial infections. The findings appear in the Journal of Clinical Microbiology. We absolutely couldn’t make these discoveries without them.”

RNA 115

RNA Hospitals Laboratories Medical Schools 115

SCIENMAG: Medicine & Health

NOVEMBER 15, 2023

The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans.

Treatment 93

Treatment Engineering Hospitals 93

Broad Institute

JULY 11, 2024

Targeted drug treatment leads tumor cells to imitate viral infection By Ari Navetta July 11, 2024 Breadcrumb Home Targeted drug treatment leads tumor cells to imitate viral infection Exploiting "viral mimicry," mIDH1 inhibitors trick tumors into thinking they are infected with a virus. paper cited Wu M, Kondo H, et al.

Treatment 72

Treatment Immune Response Drugs Virus 72

Broad Institute

AUGUST 19, 2024

A common fatty acid may help restore healthy vaginal bacteria after infection By Ari Navetta August 19, 2024 Breadcrumb Home A common fatty acid may help restore healthy vaginal bacteria after infection Treatments using oleic acid, a naturally occurring oil used in cells, could improve treatment of recurrent bacterial vaginosis infections.

Hospitals 121

Hospitals Treatment Medical Schools Science 121

SCIENMAG: Medicine & Health

AUGUST 15, 2023

By utilizing whole exome sequencing on tumor tissues and their non-tumor counterparts obtained from thirty SA-CRC patients diagnosed at Changzheng Hospital from 2014 to […]

Research 92

Research Treatment Hospitals Disease 92

KIF1A

MAY 29, 2024

Fortunately, Sloane does not currently have epilepsy, and Megan hopes this treatment will prevent it’s onset as her disease progresses. On the day of the treatment, they checked into the hospital where Sloane was administered sedation medication. The post Sloane’s 1st ASO treatment appeared first on KIF1A.

Treatment 52

Treatment Doctors Hospitals Therapies 52

Drug Target Review

MAY 23, 2025

As the biotech sector races to improve the tolerability of these revolutionary treatments, Poolbeg Pharma has a novel solution: an oral therapy, POLB 001, to block the development of CRS, by limiting inflammation without affecting the anti-cancer immune responses that are vital for effective immunotherapies.

Immune Response 52

Immune Response Therapies Treatment Clinical Trials 52

Drug Target Review

JUNE 19, 2025

As the limitations of current treatments become increasingly clear, researchers are exploring new, safer approaches. His focus, however, is on addressing a critical gap in medicine: the lack of safe, non-addictive pain treatments – a challenge that has driven the development of SRP-001. “As Dr Bazan holds a B.S.

52

52

Common Sense for Drug Policy Blog

JULY 21, 2023

Residential Treatment Compared With Outpatient Treatment Coupled With MOUD "Residential treatment is often considered the highest intensity of treatment for individuals with OUD [ 40 ], and may by particularly important for those with unstable housing, co-morbid mental health conditions, or high medical need [ 41 ].

Treatment 52

Treatment Hospitals Research 52

SCIENMAG: Medicine & Health

JULY 5, 2023

New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukaemia have been revealed by researchers at UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute.

Treatment 69

Treatment Hospitals Therapies Research 69

SCIENMAG: Medicine & Health

SEPTEMBER 22, 2023

A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial.

Clinical Trials 52

Clinical Trials Hospitals Trials Treatment 52

The Pharma Data

JANUARY 26, 2021

Zydus Cadila Healthcare’s Desidustat has demonstrated efficacy in a phase 2b clinical trial in Mexico for COVID-19 patients hospitalized with hypoxia. Zydus has two ongoing phase 3 trials evaluating Desidustat for treatment of anemia linked to chronic kidney disease and chemotherapies. Source link.

Hospitals 52

Hospitals Clinical Trials Trials Treatment 52

Conversations in Drug Development Trends

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. Innovations in Autoimmune Research: A New Era of Treatment In recent years, autoimmune and bone health research has entered a new era of innovation.

Research 52

Research Clinical Trials Therapies Immune Response 52

The Pharma Data

JUNE 9, 2025

Unlike some treatments that require dosing adjustments based on weight, ENFLONSIA simplifies administration by offering a single fixed 105 mg dose for all infants, regardless of their size. RSV disease is the leading cause of infant hospitalization in the U.S. Octavio Ramilo, Chair of the Department of Infectious Diseases at St.

FDA Approval 40

FDA Approval FDA Hospitals Clinical Trials 40

SCIENMAG: Medicine & Health

AUGUST 8, 2023

Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment control have not been fully elucidated.

Virus 89

Virus Hospitals Treatment 89

New Drug Approvals

JUNE 8, 2025

link] Ibuzatrelvir (1) was recently disclosed and patented by Pfizer for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). “A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19” Journal of Medicinal Chemistry. Hz), 4.30 (1H, d J = 9.9

Metabolic Stability 62

Metabolic Stability Treatment Clinical Trials Drugs 62

The Pharma Data

JUNE 12, 2025

The results come from a open-label, proof-of-concept, Phase 2 study (NCT04520451) and highlight rilzabrutinib’s potential as a disease-changing treatment option for a condition that currently has limited and non-specific treatment options and involves substantial patient suffering due to its chronic and progressive course.

Disease 40

Disease Clinical Development Treatment Medical Schools 40

The Pharma Data

JANUARY 11, 2021

Treatment Success Seen With Antibiotics for Uncomplicated Appendicitis. 11, 2021 — For adults with uncomplicated acute appendicitis, treatment success rates ?65 The primary end point was treatment success (?65 The researchers found that the treatment success rate at one year was 70.2 Professional. MONDAY, Jan.

Treatment 52

Treatment Hospitals Pharmaceuticals Research 52

Drug Target Review

AUGUST 29, 2024

However, these treatments will eventually fail for the majority of patients, so there is a strong need for better CAR therapies. How might the CD5 knockout approach impact the treatment of other types of cancers beyond T-cell lymphoma?

Therapies 59

Therapies Treatment Engineering Molecular Biology 59

Broad Institute

OCTOBER 3, 2024

Largest-ever genetic study of epilepsy finds possible therapeutic targets By Ari Navetta October 3, 2024 Breadcrumb Home Largest-ever genetic study of epilepsy finds possible therapeutic targets Scientists have uncovered new genetic links to different types of epilepsy, which could lead to more tailored treatments.

DNA 133

DNA Doctors Treatment Disease 133

Broad Institute

FEBRUARY 16, 2024

The way that clinicians subdivide diabetes patients now is based on symptoms, but in this study, the frequency of genetic risk factors seems to vary among patients with youth-onset T2D,” said Jason Flannick , Broad associate member and assistant professor at Boston Children’s Hospital and Harvard Medical School. “We

Medical Schools 133

Medical Schools Hospitals Disease DNA 133

Broad Institute

SEPTEMBER 18, 2024

Gram-negative bacteria such as Enterobacteriaceae are a common cause of these infections and have few treatment options. Researchers at Keio University School of Medicine in Tokyo and the Broad Institute of MIT and Harvard have isolated 18 bacterial strains from stool from healthy people that could potentially be a more effective treatment.

Medical Schools 119

Medical Schools Disease Hospitals Treatment 119

Drug Target Review

DECEMBER 16, 2024

Since their first approvals in 2017, autologous CAR T-cell therapies have revolutionised the treatment of blood cancers, offering hope where previous options had failed. Treatment outcomes for large B-cell lymphoma were dismal before CAR T-cell therapies.

Therapies 52

Therapies Clinical Trials Treatment Trials 52

Drug Target Review

JANUARY 12, 2024

How does the integration of Real-World Data (RWD) with genomic biomarker data contribute to a more comprehensive understanding of disease progression and treatment response? Biomarker information is also useful for tracking progression of the disease and treatment response. This can lead to a new treatment being offered to the patient.

Doctors 111

Doctors Clinical Trials Treatment Therapies 111